Restricted accessResearch articleFirst published online 2014-11
Early Exposure of Murine Embryonic Stem Cells to Hematopoietic Cytokines Differentially Directs Definitive Erythropoiesis and Cardiomyogenesis in Alginate Hydrogel Three-Dimensional Cultures
HepG2-conditioned medium (CM) facilitates early differentiation of murine embryonic stem cells (mESCs) into hematopoietic cells in two-dimensional cultures through formation of embryoid-like colonies (ELCs), bypassing embryoid body (EB) formation. We now demonstrate that three-dimensional (3D) cultures of alginate-encapsulated mESCs cultured in a rotating wall vessel bioreactor can be differentially driven toward definitive erythropoiesis and cardiomyogenesis in the absence of ELC formation. Three groups were evaluated: mESCs in maintenance medium with leukemia inhibitory factor (LIF, control) and mESCs cultured with HepG2 CM (CM1 and CM2). Control and CM1 groups were cultivated for 8 days in early differentiation medium with murine stem cell factor (mSCF) followed by 10 days in hematopoietic differentiation medium (HDM) containing human erythropoietin, m-interleukin (mIL)-3, and mSCF. CM2 cells were cultured for 18 days in HDM, bypassing early differentiation. In CM1, a fivefold expansion of hematopoietic colonies was observed at day 14, with enhancement of erythroid progenitors, hematopoietic genes (Gata-2 and SCL), erythroid genes (EKLF and β-major globin), and proteins (Gata-1 and β-globin), although ζ-globin was not expressed. In contrast, CM2 primarily produced beating colonies in standard hematopoietic colony assay and expressed early cardiomyogenic markers, anti-sarcomeric α-actinin and Gata-4. In conclusion, a scalable, automatable, integrated, 3D bioprocess for the differentiation of mESC toward definitive erythroblasts has been established. Interestingly, cardiomyogenesis was also directed in a specific protocol with HepG2 CM and hematopoietic cytokines making this platform a useful tool for the study of erythroid and cardiomyogenic development.
Get full access to this article
View all access options for this article.
References
1.
KennedyM, D'SouzaSL, Lynch-KattmanM, SchwantzS and KellerG. (2007). Development of the hemangioblast defines the onset of hematopoiesis in human ES cell differentiation cultures. Blood, 109:2679–2687.
2.
KouskoffV, LacaudG, SchwantzS, FehlingHJ and KellerG. (2005). Sequential development of hematopoietic and cardiac mesoderm during embryonic stem cell differentiation. Proc Natl Acad Sci U S A, 102:13170–13175.
3.
ChoiK, KennedyM, KazarovA, PapadimitriouJC and KellerG. (1998). A common precursor for hematopoietic and endothelial cells. Development, 125:725–732.
4.
KellerG, KennedyM, PapayannopoulouT and WilesMV. (1993). Hematopoietic commitment during embryonic stem-cell differentiation in culture. Mol Cell Biol, 13:473–486.
5.
PalisJ, McgrathKE and KingsleyPD. (1995). Initiation of hematopoiesis and vasculogenesis in murine yolk-sac explants. Blood, 86:156–163.
6.
PalisJ, RobertsonS, KennedyM, WallC and KellerG. (1999). Development of erythroid and myeloid progenitors in the yolk sac and embryo proper of the mouse. Development, 126:5073–5084.
7.
LuSJ, FengQ, CaballeroS, ChenY, MooreMAS, GrantMB and LanzaR. (2007). Generation of functional hemangioblasts from human embryonic stem cells. Nat Methods, 4:501–509.
8.
Van HandelB, Montel-HagenA, SasidharanR, NakanoH, FerrariR, BoogerdCJ, SchredelsekerJ, WangYL, HunterS, et al. (2012). Scl represses cardiomyogenesis in prospective hemogenic endothelium and endocardium. Cell, 150:590–605.
9.
KattmanSJ, HuberTL and KellerGM. (2006). Multipotent Flk-1(+) cardiovascular progenitor cells give rise to the cardiomyocyte, endothelial, and vascular smooth muscle lineages. Dev Cell, 11:723–732.
10.
HuberTL, KouskoffV, FehlingHJ, PalisJ and KellerG. (2004). Haemangioblast commitment is initiated in the primitive streak of the mouse embryo. Nature, 432:625–630.
11.
FehlingHJ, LacaudG, KuboA, KennedyM, RobertsonS, KellerG and KouskoffV. (2003). Tracking mesoderm induction and its specification to the hemangioblast during embryonic stem cell differentiation. Development, 130:4217–4227.
12.
LancrinC, SroczynskaP, StephensonC, AllenT, KouskoffV and LacaudG. (2009). The haemangioblast generates haematopoietic cells through a haemogenic endothelium stage. Nature, 457:892–895.
13.
EilkenHM, NishikawaSI and SchroederT. (2009). Continuous single-cell imaging of blood generation from haemogenic endothelium. Nature, 457:896–900.
14.
RhodesKE, GekasC, WangY, LuxCT, FrancisCS, ChanDN, ConwayS, OrkinSH, YoderMC and MikkolaHKA. (2008). The emergence of hematopoietic stem cells is initiated in the placental vasculature in the absence of circulation. Cell Stem Cell, 2:252–263.
15.
MigliaccioAR, WhitsettC and MigliaccioG. (2009). Erythroid cells in vitro: from developmental biology to blood transfusion products. Curr Opin Hematol, 16:259–268.
16.
LuSJ, FengQ, ParkJS, VidaL, LeeBS, StrausbauchM, WettsteinPJ, HonigGR and LanzaR. (2008). Biologic properties and enucleation of red blood cells from human embryonic stem cells. Blood, 112:4475–4484.
17.
MaF, EbiharaY, UmedaK, SakaiH, HanadaS, ZhangH, ZaikeY, TsuchidaE, NakahataT, NakauchiH and TsujiK. (2008). Generation of functional erythrocytes from human embryonic stem cell-derived definitive hematopoiesis. Proc Natl Acad Sci U S A, 105:13087–13092.
PlaczekMR, ChungIM, MacedoHM, IsmailS, BlancoTM, LimM, ChaJM, FauziI, KangY, et al. (2009). Stem cell bioprocessing: fundamentals and principles. J R Soc Interface, 6:209–232.
20.
UngrinMD, JoshiC, NicaA, BauwensC and ZandstraPW. (2008). Reproducible, ultra high-throughput formation of multicellular organization from single cell suspension-derived human embryonic stem cell aggregates. PLoS One, 3:e1565
21.
CoucouvanisE and MartinGR. (1999). BMP signaling plays a role in visceral endoderm differentiation and cavitation in the early mouse embryo. Development, 126:535–546.
22.
Hernandez-GarciaD, Castro-ObregonS, Gomez-LopezS, ValenciaC and CovarrubiasL. (2008). Cell death activation during cavitation of embryoid bodies is mediated by hydrogen peroxide. Exp Cell Res, 314:2090–2099.
23.
BauwensC, YinT, DangS, PeeraniR and ZandstraPW. (2005). Development of a perfusion fed bioreactor for embryonic stem cell-derived cardiomyocyte generation: Oxygen-mediated enhancement of cardiomyocyte output. Biotechnol Bioeng, 90:452–461.
24.
BienaimeC, BarbotinJN and Nava-SaucedoJE. (2003). How to build an adapted and bioactive cell microenvironment?. A chemical interaction study of the structure of Ca-alginate matrices and their repercussion on confined cells. J Biomed Mater Res A, 67A:376–388.
25.
MagyarJP, NemirM, EhlerE, SuterN, PerriardJC and EppenbergerHM. (2001). Mass production of embryoid bodies in microbeads. Ann N Y Acad Sci, 944:135–143.
PanoskaltsisN, MantalarisA and WuJHD. (2005). Engineering a mimicry of bone marrow tissue ex vivo. J Biosci Bioeng, 100:28–35.
28.
FokEYL and ZandstraPW. (2005). Shear-controlled single-step mouse embryonic stem cell expansion and embryoid body-based differentiation. Stem Cells, 23:1333–1342.
29.
FongWJ, TanHL, ChooA and OhSKW. (2005). Perfusion cultures of human embryonic stem cells. Bioproc Biosyst Eng, 27:381–387.
30.
FridleyKM, FernandezI, LiMT, KettlewellRB and RoyK. (2010). Unique differentiation profile of mouse embryonic stem cells in rotary and stirred tank bioreactors. Tissue Eng, 16:3285–3298.
31.
HwangYS, ChoJ, TayF, HengJYY, HoR, KazarianSG, WilliamsDR, BoccacciniAR, PolakJM and MantalarisA. (2009). The use of murine embryonic stem cells, alginate encapsulation, and rotary microgravity bioreactor in bone tissue engineering. Biomaterials, 30:499–507.
32.
RandleWL, ChaJM, HwangYS, ChanKLA, KazarianSG, PolakJM and MantalarisA. (2007). Integrated 3-dimensional expansion and osteogenic differentiation of murine embryonic stem cells. Tissue Eng, 13:2957–2970.
33.
HwangYS, RandleWL, BielbyRC, PolakJM and MantalarisA. (2006). Enhanced derivation of osteogenic cells from murine embryonic stem cells after treatment with HepG2-conditioned medium and modulation of the embryoid body formation period: application to skeletal tissue engineering. Tissue Eng, 12:1381–1392.
34.
HwangYS, BishopAE, PolakJM and MantalarisA. (2007). Enhanced in vitro chondrogenic differentiation of murine embryonic stem cells. Biotechnol Bioproc E, 12:696–706.
35.
HwangYS, PolakJM and MantalarisA. (2008). In vitro direct osteogenesis of murine embryonic stem cells without embryoid body formation. Stem Cells Dev, 17:963–970.
36.
FauziI, PanoskaltsisN and MantalarisA. (2012). Enhanced hematopoietic differentiation towards erythrocytes from murine embryonic stem cells with HepG2-conditioned medium. Stem Cells Dev, 21:3152–3161.
37.
HiroyamaT, MiharadaK, SudoK, DanjoI, AokiN and NakamuraY. (2008). Establishment of mouse embryonic stem cell-derived erythroid progenitor cell lines able to produce functional red blood cells. PLoS One, 3:e1544
38.
SchneiderCA, RasbandWS and EliceiriKW. (2012). NIH Image to ImageJ: 25 years of image analysis. Nat Methods, 9:671–675.
39.
NarlaA, DuttS, McAuleyJR, Al-ShahrourF, HurstS, McConkeyM, NeubergD and EbertBL. (2011). Dexamethasone and lenalidomide have distinct functional effects on erythropoiesis. Blood, 118:2296–2304.
40.
ObradovicB, CarrierRL, Vunjak-NovakovicG and FreedLE. (1999). Gas exchange is essential for bioreactor cultivation of tissue engineered cartilage. Biotechnol Bioeng, 63:197–205.
41.
ZetterbergA and EngstromW. (1981). Mitogenic effect of alkaline-ph on quiescent, serum-starved cells. Proc Natl Acad Sci U S A, 78:4334–4338.
42.
MochizukiH, OhnukiY and KurosawaH. (2011). Effect of glucose concentration during embryoid body (EB) formation from mouse embryonic stem cells on EB growth and cell differentiation. J Biosci Bioeng, 111:92–97.
43.
KhooMLM, McQuadeLR, SmithMSR, LeesJG, SidhuKS and TuchBE. (2005). Growth and differentiation of embryoid bodies derived from human embryonic stem cells: Effect of glucose and basic fibroblast growth factor. Biol Reprod, 73:1147–1156.
44.
ConaghanJ, HandysideAH, WinstonRML and LeeseHJ. (1993). Effects of pyruvate and glucose on the development of human preimplantation embryos in-vitro. J Reprod Fertil, 99:87–95.
45.
QuinnP. (1995). Enhanced results in mouse and human embryo culture using a modified human tubal fluid medium lacking glucose and phosphate. J Assist Reprod Gen, 12:97–105.
46.
TennantGB, TruranLN, Bailey-WoodR and BurnettAK. (2000). Control of pH in human long-term bone marrow cultures with low-glucose medium containing zwitterion buffer lengthens the period of haemopoietic activity. Br J Haematol, 109:785–787.
47.
ErardF, DeanA and SchechterAN. (1981). Inhibitors of cell-division reversibly modify hemoglobin concentration in human erythroleukemia K562 cells. Blood, 58:1236–1239.
48.
HiepNC, KinohiraS, FuruyamaK and TaketaniS. (2012). Depletion of glutamine enhances sodium butyrate-induced erythroid differentiation of K562 cells. J Biochem, 152:509–519.
49.
FlorianM, JankowskiM and GutkowskaJ. (2010). Oxytocin increases glucose uptake in neonatal rat cardiomyocytes. Endocrinology, 151:482–491.
50.
CrespoFL, SobradoVR, GomezL, CerveraAM and McCreathKJ. (2010). Mitochondrial reactive oxygen species mediate cardiomyocyte formation from embryonic stem cells in high glucose. Stem Cells, 28:1132–1142.
51.
Gerecht-NirS, CohenS and Itskovitz-EldorJ. (2004). Bioreactor cultivation enhances the efficiency of human embryoid body (hEB) formation and differentiation. Biotechnol Bioeng, 86:493–502.
52.
McAdamsTA, MillerWM and PapoutsakisET. (1998). pH is a potent modulator of erythroid differentiation. Br J Haematol, 103:317–325.
53.
BroudyVC. (1997). Stem cell factor and hematopoiesis. Blood, 90:1345–1364.
54.
MutaK, KrantzSB, BondurantMC and DaiCH. (1995). Stem-cell factor retards differentiation of normal human erythroid progenitor cells while stimulating proliferation. Blood, 86:572–580.
55.
MigliaccioG, MigliaccioAR and VisserJWM. (1988). Synergism between erythropoietin and interleukin-3 in the induction of hematopoietic stem-cell proliferation and erythroid burst colony formation. Blood, 72:944–951.
56.
GhezziP and BrinesM. (2004). Erythropoietin as an antiapoptotic, tissue-protective cytokine. Cell Death Differ, 11 (Suppl. 1):S37–S44.
57.
JiRP, PhoonCKL, AristizabalO, McGrathKE, PalisJ and TurnbullDH. (2003). Onset of cardiac function during early mouse embryogenesis coincides with entry of primitive erythroblasts into the embryo proper. Circ Res, 92:133–135.
58.
RobertsonSM, KennedyM, ShannonJM and KellerG. (2000). A transitional stage in the commitment of mesoderm to hematopoiesis requiring the transcription factor SCL/tal-l. Development, 127:2447–2459.
59.
NishikawaS, NishikawaS, HirashimaM, MatsuyoshiN and KodamaH. (1998). Progressive lineage analysis by cell sorting and culture identifies FLK1(+)VE-cadherin(+) cells at a diverging point of endothelial and hemopoietic lineages. Development, 125:1747–1757.
60.
YamaguchiTP, DumontDJ, ConlonRA, BreitmanML and RossantJ. (1993). Flk-1, an Flt-related receptor tyrosine kinase is an early marker for endothelial-cell precursors. Development, 118:489–498.
61.
KangYY, NagyJM, PolakJM and MantalarisA. (2009). Proteomic characterization of the conditioned media produced by the visceral endoderm-like cell lines HepG2 and END2: toward a defined medium for the osteogenic/chondrogenic differentiation of embryonic stem cells. Stem Cells Dev, 18:77–91.
62.
WuXC, RichardsNT and JohnsEJ. (1999). The influence of erythropoietin on the vascular responses of rat resistance arteries. Exp Physiol, 84:917–927.
63.
WuH, LeeSH, GaoJ, LiuX and Iruela-ArispeML. (1999). Inactivation of erythropoietin leads to defects in cardiac morphogenesis. Development, 126:3597–3605.
64.
BrizziMF, FormatoL, DentelliP, RossoA, PavanM, GarbarinoG, PegoraroM, CamussiG and PegoraroL. (2001). Interleukin-3 stimulates migration and proliferation of vascular smooth muscle cells—a potential role in atherogenesis. Circulation, 103:549–554.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
